GGrantIndex
Sort

82,697 grants matching vaccine development

Novel Therapeutic Strategies in Human Myeloid Leukemias

$2,191,623
D Gary Gilliland · Dana-Farber Cancer Inst · P01 · FY2006 · CA

Nano Approaches to Modulate Host Cell Response for Cancer Therapy

$2,191,356
Leaf Huang · Univ Of North Carolina Chapel Hill · U54 · FY2019 · CA

Non-Human Primate Discovery Team

$2,190,977
Norman L Letvin · Duke University · U19 · FY2011 · AI

Center for Experimental Infectious Disease Research

$2,190,854
Konstantin G Kousoulas · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2013 · GM

Obesity-driven alterations in humoral B cell immunity

$2,190,435
Elizabeth Ann Leadbetter · University Of Texas Hlth Science Center · R01 · FY2025 · AI

SPORE in Prostate Cancer

$2,190,123
Samuel R Denmeade · Johns Hopkins University · P50 · FY2024 · CA

Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09

$2,190,000
Cheryl Cohen · National Health Laboratory Service · U01 · FY2018 · IP

Allergen and T-Cell Reagent Resources for the Study of Allergic Diseases

$2,189,410
William W. Kwok · Benaroya Research Inst At Virginia Mason · N01 · FY2011 · AI

Dana Farber/Harvard Cancer Center SPORE in Lung Cancer

$2,189,154
David A Barbie · Dana-Farber Cancer Inst · P50 · FY2023 · CA

Targeting Immunogenicity to the MPER Hinge and C-helix for BNAb Elicitation

$2,189,065
Ellis L Reinherz · Dana-Farber Cancer Inst · P01 · FY2018 · AI

B Cells in Health and Disease

$2,188,962
Ignacio E. Sanz · Emory University · P01 · FY2014 · AI

SPORE in Skin Cancer

$2,186,863
Meenhard Herlyn · Wistar Institute · P50 · FY2007 · CA

HIV Vaccine Design and Development Teams, Part A- Preventative Vaccines

$2,186,845
Novartis Vaccines And Diagnostics, Inc. · N01 · FY2013 · AI

Washington University SPORE in Pancreatic Cancer

$2,186,724
William G Hawkins · Washington University · P50 · FY2016 · CA

NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LAB AIDS VACCINE R&D

$2,186,217
David C Montefiori · Duke University · N01 · FY2012 · AI

NIAID Microbiome Program

$2,185,953
Niki Moutsopoulos · National Institute Of Allergy And Infectious Diseases · ZIC · FY2025 · AI

Novel Therapeutic Strategies in Human Myeloid Leukemias

$2,185,917
Dana-Farber Cancer Institute · P01 · FY2005 · CA

Task X8: Efficacy Testing of Filovirus Vaccines in Non-Human Primates

$2,185,568
Norman Kneteman · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2013 · AI

Task X8: Efficacy Testing of Filovirus Vaccines in Non-Human Primates

$2,185,567
Norman Kneteman · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2013 · AI

Clinical Trials of Parainfluenza and Respiratory Syncytial Virus Vaccines

$2,185,305
Brian Murphy · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Mayo Clinic SPORE in Pancreatic Cancer

$2,185,002
Gloria M. Petersen · Mayo Clinic Rochester · P50 · FY2015 · CA

Duke SPORE in Brain Cancer

$2,185,000
John H Sampson · Duke University · P50 · FY2015 · CA

Seattle Cancer Consortium Breast SPORE

$2,185,000
Peggy L Porter · Fred Hutchinson Cancer Research Center · P50 · FY2011 · CA

Mayo Clinic SPORE in Ovarian Cancer

$2,185,000
Lynn C. Hartmann · Mayo Clinic Rochester · P50 · FY2011 · CA

M. D. Anderson Cancer Center SPORE in Multiple Myeloma

$2,185,000
Robert Zygmunt Orlowski · University Of Tx Md Anderson Can Ctr · P50 · FY2011 · CA